2 insider filings
Susan Gani Kozauer, insider filing for LBRX
Show all 2
- 4Insider filing for LBRX
- 4Insider filing for LBRX
Susan Gani Kozauer, reporting
LBRX
LB PHARMACEUTICALS INC SEC filings
Every EDGAR filing for LB PHARMACEUTICALS INC (LBRX), newest first, with AI summaries and stories.
- Ticker
- LBRX
- CIK
- 1691082
- Latest filing
- 5d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4LB PHARMACEUTICALS INCLBRXLIVE ROUTINESCHEDULE 13G/ALB PHARMACEUTICALS INCLBRXLIVE LB Pharmaceuticals Inc reports JPMorgan stake
- JPMorgan Chase & Co. owns 4.3% of LB Pharmaceuticals Inc.
- Beneficially owned shares: 1,401,790.
- Sole voting power: 1,334,100.
JPMORGAN CHASE & CO, filed by
ROUTINEEFFECTLB PHARMACEUTICALS INCLBRXLIVE LB Pharmaceuticals Inc files Form EFFECT
- Filed on 2026-10-05
- Accession number 0001193125-26-410664
- Submission type POS AM
ROUTINEPOS AMLB PHARMACEUTICALS INCLBRXLIVE ROUTINES-3ASRLB PHARMACEUTICALS INCLBRXLIVE ROUTINE3LB PHARMACEUTICALS INCLBRXLIVE Susan Gani Kozauer, new insider at LBRX
Susan Gani Kozauer, reporting
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINE3LB PHARMACEUTICALS INCLBRXLIVE Joseph M Miller, new insider at LBRX
Joseph M Miller, reporting
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINESCHEDULE 13G/ALB PHARMACEUTICALS INCLBRXLIVE Ownership stake disclosure by TCG Crossover GP II, LLC (amended)
TCG Crossover GP II, LLC, filed by
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE NOTABLE10-QLB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINE4LB PHARMACEUTICALS INCLBRXLIVE David Kroin, insider filing for LBRX
David Kroin, reporting · Deep Track Capital, LP, reporting · +1 more
ROUTINESCHEDULE 13G/ALB PHARMACEUTICALS INCLBRXLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINESCHEDULE 13GLB PHARMACEUTICALS INCLBRXLIVE Ownership stake disclosure by JPMORGAN CHASE & CO
JPMORGAN CHASE & CO, filed by
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINE144LB PHARMACEUTICALS INCLBRXLIVE Zachary Prensky, planned sale of LBRX shares
Zachary Prensky, reporting
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINE4LB PHARMACEUTICALS INCLBRXLIVE 7 insider filings
Robert R Ruffolo, insider filing for LBRX
Show all 7
- 4Insider filing for LBRX
- 4Insider filing for LBRX
- 4Insider filing for LBRX
- 4Insider filing for LBRX
- 4Insider filing for LBRX
- 4Insider filing for LBRX
- 4Insider filing for LBRX
Robert R Ruffolo, reporting
ROUTINESCHEDULE 13G/ALB PHARMACEUTICALS INCLBRXLIVE 2 13G filings
Ownership stake disclosure by TCG Crossover GP II, LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
TCG Crossover GP II, LLC, filed by
ROUTINESCHEDULE 13GLB PHARMACEUTICALS INCLBRXLIVE Ownership stake disclosure by Caligan Partners LP
Caligan Partners LP, filed by
ROUTINESCHEDULE 13G/ALB PHARMACEUTICALS INCLBRXLIVE Ownership stake disclosure by JPMORGAN CHASE & CO (amended)
JPMORGAN CHASE & CO, filed by
ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE NOTABLE10-QLB PHARMACEUTICALS INCLBRXLIVE ROUTINE8-KLB PHARMACEUTICALS INCLBRXLIVE ROUTINEARSLB PHARMACEUTICALS INCLBRXLIVE ROUTINEDEFA14ALB PHARMACEUTICALS INCLBRXLIVE ROUTINEDEF 14ALB PHARMACEUTICALS INCLBRXLIVE ROUTINEEFFECTLB PHARMACEUTICALS INCLBRXLIVE ROUTINE424B3LB PHARMACEUTICALS INCLBRXLIVE NOTABLES-1LB PHARMACEUTICALS INCLBRXLIVE ROUTINES-8LB PHARMACEUTICALS INCLBRXLIVE NOTABLE10-KLB PHARMACEUTICALS INCLBRXLIVE